106-08-1 Usage
Uses
Used in Pharmaceutical Industry:
Dodecanoic acid, 26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl ester is used as a pharmaceutical agent for its potential health benefits. The antimicrobial and anti-inflammatory properties of lauric acid, combined with the specific properties of the octaoxahexacos-1-yl ester, may contribute to the development of new drugs or therapies.
Used in Cosmetics Industry:
In the cosmetics industry, Dodecanoic acid, 26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl ester is used as an ingredient in various cosmetic products. The combination of lauric acid and the octaoxahexacos-1-yl ester may provide moisturizing, anti-inflammatory, and antimicrobial effects, making it suitable for skincare and hair care products.
Used in Food Production:
Dodecanoic acid, 26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl ester is used in food production as a natural preservative and flavor enhancer. The antimicrobial properties of lauric acid can help extend the shelf life of food products, while the specific properties of the octaoxahexacos-1-yl ester may contribute to the overall taste and texture.
Check Digit Verification of cas no
The CAS Registry Mumber 106-08-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,0 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 106-08:
(5*1)+(4*0)+(3*6)+(2*0)+(1*8)=31
31 % 10 = 1
So 106-08-1 is a valid CAS Registry Number.
InChI:InChI=1/C30H60O11/c1-2-3-4-5-6-7-8-9-10-11-30(32)41-29-28-40-27-26-39-25-24-38-23-22-37-21-20-36-19-18-35-17-16-34-15-14-33-13-12-31/h31H,2-29H2,1H3
106-08-1Relevant academic research and scientific papers
Combinatorial synthesis of PEG oligomer libraries
-
Page/Page column 11, (2010/02/15)
A simple chain-extending approach was established for the scale-up of the monoprotected monodisperse PEG diol materials. Reactions of THP-(OCH2CH2)n—OMs (n=4, 8, 12) with a large excess of commercially available H—(OCH2CH2)n—OH (n=1-4) under basic conditions led to THP-(OCH2CH2)n—OH (n=5-15). Similarly, Me-(OCH2CH2)n—OH (n=4-11, 13) were prepared from Me-(OCH2CH2)n—OMs (n=3, 7, 11). For the chain elongation steps, 40-80% yields were achieved through extraction purification. PEG oligomer libraries I and II were generated in 50-95% overall yields by alkylation or acylation of THP-(OCH2CH2)n—OH (n=1-15) followed by deprotection. Alkylation of Me-(OCH2CH2)n—OH (n=1-11, 13) with X—(CH2)m—CO2R (X=Br or OMs) and subsequent hydrolysis led to PEG oligomer library III in 30-60% overall yields. Combinatorial purification techniques were adapted to the larger-scale library synthesis. A total of 498 compounds, each with a weight of 2-5 g and a minimum purity of 90%, were synthesized.
